Alterations of pulmonary function in patients with inflammatory bowel diseases.

Authors:
Mahmood Dhahir Al-Mendalawi
Mahmood Dhahir Al-Mendalawi
Al-Kindy College of Medicine

Ann Thorac Med 2017 Apr-Jun;12(2):129

Department of Pediatrics, Al-Kindy College of Medicine, Baghdad University, Baghdad, Iraq. E-mail:

Download full-text PDF

Source
http://dx.doi.org/10.4103/atm.ATM_350_16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399689PMC
May 2017
3 Reads

Publication Analysis

Top Keywords

inflammatory bowel
4
bowel diseases
4
patients inflammatory
4
function patients
4
alterations pulmonary
4
pulmonary function
4
diseases
1
alterations
1
function
1
bowel
1
patients
1
inflammatory
1

Similar Publications

Alterations in the pulmonary function tests of inflammatory bowel diseases.

Turk J Gastroenterol 2011 Jun;22(3):293-9

Department of Gastroenterology, Mersin University School of Medicine, Mersin, Turkey.

Background/aims: We aimed to determine the changes in the pulmonary function tests of the patients with inflammatory bowel diseases.

Methods: Forty inflammatory bowel dieases patients; 30 ulcerative colitis and 10 Crohn's disease, and ageand sex-matched control group, consisting of 30 healthy persons, were included in the study. Disease activity in patients with ulcerative colitis was assessed by Truelove and Witts Criteria and in Crohn's disease patients by Chron's Disease Activity Index. Read More

View Article
June 2011

Alterations of pulmonary function in patients with inflammatory bowel diseases.

Ann Thorac Med 2016 Oct-Dec;11(4):249-253

Department of Respiratory Medicine, Shandong Provincial Qianfoshan Hospital, Jinan 250014, Shandong Province, China.

Aim: The aim of this study was to investigate the alterations of pulmonary function tests (PFTs) and their relationship with disease activity in inflammatory bowel diseases (IBDs).

Methods: Sixty-four IBD patients (31 Crohn's disease [CD] and 33 ulcerative colitis [UC]) and thirty healthy individuals (controls) were studied with regard to the following parameters of PFTs: Forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), their ratio, mid-forced expiratory flow of 25-75% (FEF 25-75), residual volume, total lung capacity, and diffusing capacity of the lung for carbon monoxide (DLCO). The disease activity was calculated using the Crohn's Disease Activity Index for CD and Mayo Clinic Score for UC. Read More

View Article
November 2016

Pulmonary function tests, high-resolution computed tomography findings and inflammatory bowel disease.

Acta Gastroenterol Belg 2006 Jul-Sep;69(3):255-60

Gastroenterology Department, Turkiye Yuksek Ihtisas Hospital, Ankara, Turkey.

Aim: The association between inflammatory bowel disease and pulmonary involvement has not been clearly established. The aim of this prospective study was to define the features of pulmonary function tests and high resolution computed tomography in inflammatory bowel disease patients and the relation between these and disease activity.

Method: Fifty-two patients with inflammatory bowel disease (20 with Crohn's disease and 32 with ulcerative colitis) were enrolled. Read More

View Article
June 2007

Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases.

World J Gastroenterol 2013 Oct;19(40):6794-804

Hui Wang, Jing-Shi Liu, Shao-Hua Peng, Xi-Yun Deng, De-Mao Zhu, Sara Javidiparsijani, Gui-Rong Wang, Dai-Qiang Li, Long-Xuan Li, Yi-Chun Wang, Jun-Ming Luo, Department of Radiation Oncology, the Affiliated Hunan Provincial Tumor Hospital, Xiangya Medical School, Central South University, Changsha 410013, Hunan Province, China.

Pulmonary abnormalities, dysfunction or hyper-reactivity occurs in association with inflammatory bowel disease (IBD) more frequently than previously recognized. Emerging evidence suggests that subtle inflammation exists in the airways among IBD patients even in the absence of any bronchopulmonary symptoms, and with normal pulmonary functions. The pulmonary impairment is more pronounced in IBD patients with active disease than in those in remission. Read More

View Article
October 2013